151 related articles for article (PubMed ID: 25335093)
1. Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements.
Xiao F; Chen J; Lian C; Han P; Zhang C
Mol Med Rep; 2015 Jan; 11(1):739-45. PubMed ID: 25335093
[TBL] [Abstract][Full Text] [Related]
2. Selective TRAIL-induced cytotoxicity to lung cancer cells mediated by miRNA response elements.
Wu G; Ji Z; Li H; Lei Y; Jin X; Yu Y; Sun M
Cell Biochem Funct; 2014 Oct; 32(7):547-56. PubMed ID: 25132116
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
Yan Y; Zhang F; Fan Q; Li X; Zhou K
Neoplasma; 2014; 61(6):672-9. PubMed ID: 25150312
[TBL] [Abstract][Full Text] [Related]
4. microRNA response elements-regulated TRAIL expression shows specific survival-suppressing activity on bladder cancer.
Zhao Y; Li Y; Wang L; Yang H; Wang Q; Qi H; Li S; Zhou P; Liang P; Wang Q; Li X
J Exp Clin Cancer Res; 2013 Feb; 32(1):10. PubMed ID: 23442927
[TBL] [Abstract][Full Text] [Related]
5. MiRNA-mediated tumor specific delivery of TRAIL reduced glioma growth.
Bo Y; Guo G; Yao W
J Neurooncol; 2013 Mar; 112(1):27-37. PubMed ID: 23338605
[TBL] [Abstract][Full Text] [Related]
6. MiRNA regulation of TRAIL expression exerts selective cytotoxicity to prostate carcinoma cells.
Huo W; Jin N; Fan L; Wang W
Mol Cell Biochem; 2014 Mar; 388(1-2):123-33. PubMed ID: 24292881
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-661 Enhances TRAIL or STS Induced Osteosarcoma Cell Apoptosis by Modulating the Expression of Cytochrome c1.
Fan L; Zhu C; Qiu R; Zan P; Zheng Z; Xu T; Li G
Cell Physiol Biochem; 2017; 41(5):1935-1946. PubMed ID: 28391262
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.
Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; Rédini F
Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692
[TBL] [Abstract][Full Text] [Related]
9. Efficient melanoma cell killing and reduced melanoma growth in mice by a selective replicating adenovirus armed with tumor necrosis factor-related apoptosis-inducing ligand.
Fecker LF; Rückert S; Kurbanov BM; Schmude M; Stockfleth E; Fechner H; Eberle J
Hum Gene Ther; 2011 Apr; 22(4):405-17. PubMed ID: 20977303
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated ING4 Gene Transfer in Osteosarcoma Suppresses Tumor Growth via Induction of Apoptosis and Inhibition of Tumor Angiogenesis.
Xu M; Xie Y; Sheng W; Miao J; Yang J
Technol Cancer Res Treat; 2015 Aug; 14(4):369-78. PubMed ID: 25326586
[TBL] [Abstract][Full Text] [Related]
11. Cancer gene therapy using a novel secretable trimeric TRAIL.
Kim CY; Jeong M; Mushiake H; Kim BM; Kim WB; Ko JP; Kim MH; Kim M; Kim TH; Robbins PD; Billiar TR; Seol DW
Gene Ther; 2006 Feb; 13(4):330-8. PubMed ID: 16195699
[TBL] [Abstract][Full Text] [Related]
12. Selective expression of tumor necrosis factor-related apoptosis-inducing ligand mediated by microRNA suppresses renal carcinoma growth.
Zhang Z; Zhang H; Li H; Chen X; Liu M; Liu D; Zhao Y; Kong X
Mol Cell Biochem; 2014 Jul; 392(1-2):125-34. PubMed ID: 24788726
[TBL] [Abstract][Full Text] [Related]
13. Esophageal cancer-selective expression of TRAIL mediated by MREs of miR-143 and miR-122.
Zhou K; Yan Y; Zhao S
Tumour Biol; 2014 Jun; 35(6):5787-95. PubMed ID: 24659424
[TBL] [Abstract][Full Text] [Related]
14. Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
Patiño-García A; Zalacain M; Folio C; Zandueta C; Sierrasesúmaga L; San Julián M; Toledo G; De Las Rivas J; Lecanda F
Clin Cancer Res; 2009 Aug; 15(16):5082-91. PubMed ID: 19671856
[TBL] [Abstract][Full Text] [Related]
15. Triazine-modified dendrimer for efficient TRAIL gene therapy in osteosarcoma.
Wang Y; Li L; Shao N; Hu Z; Chen H; Xu L; Wang C; Cheng Y; Xiao J
Acta Biomater; 2015 Apr; 17():115-24. PubMed ID: 25595474
[TBL] [Abstract][Full Text] [Related]
16. Radiation-inducible human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy: a novel treatment for radioresistant uveal melanoma.
Zhou Y; Song X; Jia R; Wang H; Dai L; Xu X; Gu P; Ge S; Fan X
Pigment Cell Melanoma Res; 2010 Oct; 23(5):661-74. PubMed ID: 20546535
[TBL] [Abstract][Full Text] [Related]
17. Decreased miR-134 expression and its tumor-suppressive function in human osteosarcoma.
Bao Y; Peng L; Ma J; Liu K; Li W
Genet Mol Res; 2015 Dec; 14(4):16771-81. PubMed ID: 26681023
[TBL] [Abstract][Full Text] [Related]
18. Tumor-targeting TRAIL expression mediated by miRNA response elements suppressed growth of uveal melanoma cells.
Liu J; Ma L; Li C; Zhang Z; Yang G; Zhang W
Mol Oncol; 2013 Dec; 7(6):1043-55. PubMed ID: 24001901
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor-related apoptosis inducing ligand in osteosarcoma pre-clinical models.
Guiho R; Biteau K; Grisendi G; Chatelais M; Brion R; Taurelle J; Renault S; Heymann D; Dominici M; Redini F
Cytotherapy; 2018 Aug; 20(8):1037-1045. PubMed ID: 30093324
[TBL] [Abstract][Full Text] [Related]
20. Sensitization of multidrug resistant human ostesarcoma cells to Apo2 Ligand/TRAIL-induced apoptosis by inhibition of the Akt/PKB kinase.
Cenni V; Maraldi NM; Ruggeri A; Secchiero P; Del Coco R; De Pol A; Cocco L; Marmiroli S
Int J Oncol; 2004 Dec; 25(6):1599-608. PubMed ID: 15547696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
